RAIA DROGASIL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.07 BRL | -2.83% |
|
-3.80% | -14.73% |
| May. 08 | Transcript : Raia Drogasil S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| May. 07 | Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Raia Drogasil S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.01% | 17 M€ | -8.09% | - | |
| 1.35% | 12 M€ | +15.09% | - | |
| 1.21% | 14 M€ | -4.02% | ||
| 1.19% | 0 M€ | -6.18% | ||
| 0.28% | 11 M€ | +2.67% | ||
| 0.11% | 454 M€ | +4.02% | - | |
| 0.11% | 2,867 M€ | +5.89% | - | |
| 0.11% | 153 M€ | +3.74% | - | |
| 0.09% | 4 M€ | -4.41% | - | |
| 0.05% | 112 M€ | +4.61% | - | |
| 0.03% | 7 M€ | +5.36% | - | |
| 0.01% | 45 M€ | -.--% | - | |
| 0.01% | 34 M€ | +3.86% | - | |
| 0.01% | 391 M€ | +7.63% | - | |
| 0.00% | 34 M€ | +8.09% | - | |
| 0.00% | 39 M€ | +5.00% | - | |
| 0.00% | 306 M€ | +5.07% | - | |
| 0.00% | 25 M€ | -.--% | - | |
| 0.00% | 146 M€ | -2.63% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 105 M€ | +2.97% | - | |
| 0.00% | 1 M€ | -.--% | - | |
| 0.00% | 29 M€ | -2.15% | - | |
| 0.00% | 17 M€ | +2.48% | - | |
| 0.00% | 15 M€ | +13.60% | ||
| 0.00% | 54 M€ | +0.47% | - | |
| 0.00% | 8 M€ | +0.18% | - |
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Sector
Drug Retailers
Calendar
2024-08-05
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
25.07
BRL
Average target price
30.5
BRL
Spread / Average Target
+21.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.73% | 8.5B | |
| +30.76% | 1.29B | |
| -9.96% | 345M | |
| +11.11% | 229M | |
| -10.09% | 86.22M | |
| -43.65% | 82.6M | |
| +24.09% | 62.2M |
- Stock Market
- Equities
- RADL3 Stock
- Funds and ETFs Raia Drogasil S.A.
